Efficacy and safety of novel oral anticoagulants in clinical practice: a report from three centers in Sweden.

Ashkan Labaf; Martin Carlwe; Peter Svensson

doi:10.1186/s12959-014-0029-6

Efficacy and safety of novel oral anticoagulants in clinical practice: a report from three centers in Sweden.

Ashkan Labaf, Martin Carlwe, Peter Svensson

Clinical Coagulation, Malmö

Research output: Contribution to journal › Article › peer-review

189 Downloads (Pure)

Abstract

In clinical trials new oral anticoagulants (NOAC) have proved to be as effective as warfarin for thromboprophylaxis in atrial fibrillation. The aim of this study was to evaluate the efficacy and safety of these drugs in clinical practise.

Original language	English
Article number	29
Journal	Thrombosis Journal
Volume	12
Issue number	1
DOIs	https://doi.org/10.1186/s12959-014-0029-6
Publication status	Published - 2014

Subject classification (UKÄ)

Cardiology and Cardiovascular Disease

Access to Document

10.1186/s12959-014-0029-6

BMC_Labaf_et_al

http://www.ncbi.nlm.nih.gov/pubmed/25506268?dopt=Abstract

Cite this

@article{f888bfbed101458592879c9ffc5af7bd,

title = "Efficacy and safety of novel oral anticoagulants in clinical practice: a report from three centers in Sweden.",

abstract = "In clinical trials new oral anticoagulants (NOAC) have proved to be as effective as warfarin for thromboprophylaxis in atrial fibrillation. The aim of this study was to evaluate the efficacy and safety of these drugs in clinical practise.",

author = "Ashkan Labaf and Martin Carlwe and Peter Svensson",

year = "2014",

doi = "10.1186/s12959-014-0029-6",

language = "English",

volume = "12",

journal = "Thrombosis Journal",

issn = "1477-9560",

publisher = "BioMed Central (BMC)",

number = "1",

}

TY - JOUR

T1 - Efficacy and safety of novel oral anticoagulants in clinical practice: a report from three centers in Sweden.

AU - Labaf, Ashkan

AU - Carlwe, Martin

AU - Svensson, Peter

PY - 2014

Y1 - 2014

N2 - In clinical trials new oral anticoagulants (NOAC) have proved to be as effective as warfarin for thromboprophylaxis in atrial fibrillation. The aim of this study was to evaluate the efficacy and safety of these drugs in clinical practise.

AB - In clinical trials new oral anticoagulants (NOAC) have proved to be as effective as warfarin for thromboprophylaxis in atrial fibrillation. The aim of this study was to evaluate the efficacy and safety of these drugs in clinical practise.

U2 - 10.1186/s12959-014-0029-6

DO - 10.1186/s12959-014-0029-6

M3 - Article

C2 - 25506268

SN - 1477-9560

VL - 12

JO - Thrombosis Journal

JF - Thrombosis Journal

IS - 1

M1 - 29

ER -

Efficacy and safety of novel oral anticoagulants in clinical practice: a report from three centers in Sweden.

Abstract

Subject classification (UKÄ)

Access to Document

Fingerprint

Cite this